LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Accueil・Liste d'Actions・Moderna Inc

Moderna Inc

Fermé

Secteur Soins de santé

72.88 -0.48

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

72.16

Max

73.08

Chiffres clés
By Trading Economics
Revenu	-104M -1.3B
Ventes	-167B 241M
P/E Moyenne du Secteur	35.86 103.001
BPA	-3.33
Marge bénéficiaire	-530.705
Employés	5,600
EBITDA	-109M -1.2B

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+76.62 upside

Dividendes
By Dow Jones
Prochains Résultats	31 oct. 2024

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-65M 30B
Ouverture précédente	73.36
Clôture précédente	72.88

Sentiment de l'Actualité

By Acuity

31%

69%

58 / 365 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Weak Bullish Evidence

71.62 / 77.46 Support & Résistance

Moderna Inc Graphique

Actualités Associées

13 déc. 2023, 13:16 UTC

Principaux Mouvements du Marché

Moderna Shares, Other Covid Vaccine Makers Hit by Warning From Pfizer

14 oct. 2023, 00:02 UTC

Actions en Tendance

Stocks to Watch: Pfizer, Moderna, Lululemon Athletica

11 sept. 2023, 11:39 UTC

Principaux Mouvements du Marché

Immatics Shares Rise Premarket on Collaboration With Moderna

6 sept. 2024, 11:00 UTC

Actualités

Pandemic Darling Moderna Needs a Reality Check -- Heard on the Street -- WSJ

3 sept. 2024, 04:00 UTC

Actualités

Novo, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring -- Barrons.com

23 août 2024, 18:38 UTC

Actualités

The U.S. Is Bringing Back Free Covid Tests This Fall -- Barrons.com

2 août 2024, 21:29 UTC

Actualités

The Score: CrowdStrike, Apple, Intel and More Stocks That Defined the Week -- WSJ

1 août 2024, 10:30 UTC

Actualités

Moderna Cuts Revenue Guidance Amid Steeper Competition -- Barrons.com

3 juil. 2024, 14:18 UTC

Acquisitions, Fusions, Rachats

GSK Will Pay Up to $1.5 Billion for CureVac's mRNA Vaccines -- Barrons.com

30 mai 2024, 19:45 UTC

Actualités

Bird Flu Confirmed in Third Farmworker. It's the First Case With Respiratory Symptoms. -- Barrons.com

29 mai 2024, 15:56 UTC

Résultats

Acquisitions, Fusions, Rachats

The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why. -- Barrons.com

10 mai 2024, 20:11 UTC

Résultats

These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital, JFrog, SoundHound, and More -- Barrons.com

10 mai 2024, 14:49 UTC

Résultats

Actions en Tendance

Stocks to Watch Friday: TSMC, Novavax, Nvidia -- WSJ

2 mai 2024, 13:46 UTC

Résultats

Actions en Tendance

Stocks to Watch Thursday: Carvana, NIO, Qualcomm, Peloton -- WSJ

2 mai 2024, 10:31 UTC

Résultats

Moderna Puts Up Big Quarterly Beat; Could Shares Notch A Breakout? -- IBD

2 mai 2024, 09:08 UTC

Actions en Tendance

Stocks to Watch Thursday: Shell, Novo Nordisk, Apple -- WSJ

28 févr. 2024, 14:14 UTC

Résultats

Novavax Stock Sinks as Revenue Misses Estimates in 'Transition Year' -- Barrons.com

22 févr. 2024, 16:00 UTC

Actualités

Moderna Is Pivoting From Covid and the Results Are on Their Way -- Heard on the Street -- WSJ

22 févr. 2024, 12:40 UTC

Résultats

Moderna Stock Jumps on Surprise Profit After Earnings Beat. What to Expect in 2024. -- Barrons.com

2 nov. 2023, 16:53 UTC

Résultats

Moderna Tumbles As Light Guidance And Steep Losses Overshadow Sales Beat -- IBD

2 nov. 2023, 08:58 UTC

Résultats

These Stocks Are Moving the Most Today: Qualcomm, PayPal, SolarEdge, Roku, DoorDash, E.l.f. Beauty, and More -- Barrons.com

31 oct. 2023, 16:35 UTC

Actualités

Résultats

Nevermind Covid, Investors Want a Pfizer Obesity Pill -- Heard on the Street -- WSJ

17 oct. 2023, 10:00 UTC

Actualités

Pfizer Looks for a Covid Bottom -- Heard on the Street -- WSJ

26 sept. 2023, 09:30 UTC

Actualités

The Big Pharma Stock Trade: Weight Loss Is In, Covid-19 Is Out -- WSJ

13 sept. 2023, 12:00 UTC

Actualités

Moderna Rises on Positive Results From Flu Vaccine, and Other Plans to Move Beyond Covid -- Barrons.com

12 sept. 2023, 13:00 UTC

Actualités

CDC Advisers Weigh Covid-19 Booster Guidance as Latest Variants Spread -- WSJ

11 sept. 2023, 18:27 UTC

Actualités

FDA Approves Newest Covid-19 Boosters -- Update

11 sept. 2023, 17:55 UTC

Actualités

FDA Approves Newest Covid-19 Boosters -- WSJ

11 sept. 2023, 11:24 UTC

Principaux Mouvements du Marché

Immatics Shares Rise Premarket on Collaboration With Moderna >IMTX

Comparaison

Variation de prix

Moderna Inc prévision

Objectif de Prix

By TipRanks

76.62% hausse

Prévisions sur 12 Mois

Moyen 129.71 USD 76.62%

Haut 310 USD

Bas 58 USD

Basé sur 19 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

19 ratings

Achat

Maintien

Vente

Basé sur 19 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

71.62 / 77.46Support & Résistance

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

58 / 365Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Moderna Inc

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. The Company develops technologies that enable the development of mRNA medicines.